Study
Accelerated Resolution of Pacemaker Pocket Hematoma With Adjunctive Phototherapy: A Case Report.
James R Kneller · Cureus · 2025
Read the original paper ↗The short version
This case report followed one patient whose pacemaker surgery left a large pocket hematoma — a collection of blood at the implant site that usually resolves slowly and raises infection risk. The treating cardiologist added wearable "phototherapy" patches (LifeWave products such as X39), small adhesive discs claimed to reflect the body's own infrared light back into tissue, some placed over acupuncture points (specific body locations used in Traditional Chinese Medicine). Because this is a single case, there was no comparison group. Instead, the author asked experts how long such a hematoma would normally take to resolve and compared the patient's course against that survey: the hematoma cleared roughly six times faster than expected, a collapsed-lung complication also resolved quickly, and the patient reported side benefits like less arthritis pain and better sleep. The mechanism claims come mostly from manufacturer-linked sources — that the patches raise a regenerative peptide (GHK), boost carnosine (a molecule supporting cellular energy), or raise glutathione (a major antioxidant) by 300%. None of that was independently verified here, and the report itself says the products have not been evaluated by the US FDA and are not intended to treat medical conditions. The honest reading: an interesting anecdote, correctly labeled hypothesis-generating by its own author. One patient, no controls, a survey as the comparator, and commercial products with unverified mechanisms — this sits at the lowest tier of evidence and supports no treatment decision. It earns a place in the library only as documentation of an emerging device claim that future controlled studies would need to test.
Key findings
- A pocket hematoma is a collection of blood at a pacemaker implant site; it usually resolves slowly and raises infection risk.
- In this single case, the hematoma resolved about six times faster than an expert survey predicted while the patient wore commercial phototherapy patches, some over acupuncture points.
- The patches' claimed mechanism — reflecting the body's own infrared light to raise regenerative molecules like GHK and glutathione — was not independently verified in this report.
- The author states plainly that causality cannot be inferred and that the products are not FDA-evaluated and not intended to treat medical conditions.
- A case report is the lowest tier of clinical evidence; controlled studies would be required before any conclusion.
Common questions
What healing modality was studied?
Adhesive cutaneous phototherapy patches (LifeWave X39, Carnosine, and Glutathione products), claimed to reflect the body's own near-infrared emissions; some were placed over acupuncture points.
What condition was addressed?
A large pacemaker pocket hematoma with an associated pneumothorax in one patient, with anecdotal ancillary reports including arthritis pain relief.
What were the main findings?
Approximately sixfold faster hematoma resolution than an expert consensus survey predicted, faster pneumothorax resolution, and reported improvements in pain, balance, appetite, and sleep — in one uncontrolled case.
How strong is the evidence?
The lowest tier: a single case report with a survey-based comparator, manufacturer-derived mechanism claims, and products the report itself notes are not FDA-evaluated.
What are the clinical implications?
None — the author labels the findings hypothesis-generating and states causality cannot be inferred. Controlled trials would be needed to test the claim.
This summary and its findings were generated by AI from the published paper and may contain imperfections. It describes a study and is not medical advice — talk to a qualified clinician about your own health (terms). The original study is always the source of truth — read it above.